Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity

Molecular Metabolism

Volumn 5, Issue 1, 2016, Pages 34-46

  Nixon, Mark ^a,d   Stewart Fitzgibbon, Randi ^a,b   Fu, Jingqi ^a,e   Akhmedov, Dmitry ^a   Rajendran, Kavitha ^a   Mendoza Rodriguez, Maria G ^a   Rivera Molina, Yisel A ^a,f   Gibson, Micah ^a   Berglund, Eric D ^c   Justice, Nicholas J ^a,b   Berdeaux, Rebecca ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e CHINA MEDICAL UNIVERSITY   (China)

^f UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

CREB; CRTC; Gluconeogenesis; Insulin resistance; Salt inducible kinase; SIK1

Indexed keywords

INSULIN; MESSENGER RNA; REGULATOR PROTEIN; SALT INDUCIBLE KINASE 1; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLYCEMIC CONTROL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; SIGNAL TRANSDUCTION; SIK1 GENE; SKELETAL MUSCLE;

EID: 84952876726     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.10.004     Document Type: Article

References (45)

1. Ramnanan C.J., Edgerton D.S., Kraft G., Cherrington A.D. Physiologic action of glucagon on liver glucose metabolism. Diabetes, Obesity & Metabolism 2011, 13(Suppl 1):118-125.
2. Saltiel A.R., Kahn C.R. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001, 414:799-806.
3. Herzig S., Long F., Jhala U.S., Hedrick S., Quinn R., Bauer A., et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001, 413:179-183.
4. Koo S.H., Flechner L., Qi L., Zhang X., Screaton R.A., Jeffries S., et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111.
5. Dentin R., Liu Y., Koo S.H., Hedrick S., Vargas T., Heredia J., et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 2007, 449:366-369.
6. Wang Y., Inoue H., Ravnskjaer K., Viste K., Miller N., Liu Y., et al. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:3087-3092.
7. Le Lay J., Tuteja G., White P., Dhir R., Ahima R., Kaestner K.H. CRTC2 (TORC2) contributes to the transcriptional response to fasting in the liver but is not required for the maintenance of glucose homeostasis. Cell Metabolism 2009, 10:55-62.
8. Dentin R., Hedrick S., Xie J., Yates J., Montminy M. Hepatic glucose sensing via the CREB coactivator CRTC2. Science 2008, 319:1402-1405.
9. Saberi M., Bjelica D., Schenk S., Imamura T., Bandyopadhyay G., Li P., et al. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. American Journal of Physiology - Endocrinology and Metabolism 2009.
10. Erion D.M., Ignatova I.D., Yonemitsu S., Nagai Y., Chatterjee P., Weismann D., et al. Prevention of hepatic steatosis and hepatic insulin resistance by knockdown of cAMP response element-binding protein. Cell Metabolism 2009, 10:499-506.
11. Screaton R.A., Conkright M.D., Katoh Y., Best J.L., Canettieri G., Jeffries S., et al. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74.
12. Katoh Y., Takemori H., Lin X.Z., Tamura M., Muraoka M., Satoh T., et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS Journal 2006, 273:2730-2748.
13. Jansson D., Ng A.C., Fu A., Depatie C., Al Azzabi M., Screaton R.A. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10161-10166.
14. Berdeaux R. Metabolic regulation by salt inducible kinases. Frontiers in Biology 2011, 6:231-241.
15. Horike N., Takemori H., Katoh Y., Doi J., Min L., Asano T., et al. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2. Journal of Biological Chemistry 2003, 278:18440-18447.
16. Kim M.J., Park S.K., Lee J.H., Jung C.Y., Sung D.J., Park J.H., et al. Salt inducible kinase 1 terminates cAMP signaling by an evolutionarily conserved negative feedback loop in beta cells. Diabetes 2015.
17. Berdeaux R., Goebel N., Banaszynski L., Takemori H., Wandless T., Shelton G.D., et al. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nature Medicine 2007, 13:597-603.
18. Stewart R., Akhmedov D., Robb C., Leiter C., Berdeaux R. Regulation of SIK1 abundance and stability is critical for myogenesis. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:117-122.
19. Bruno N.E., Kelly K.A., Hawkins R., Bramah-Lawani M., Amelio A.L., Nwachukwu J.C., et al. Creb coactivators direct anabolic responses and enhance performance of skeletal muscle. EMBO Journal 2014, 33:1027-1043.
20. Stewart R., Flechner L., Montminy M., Berdeaux R. CREB is activated by muscle injury and promotes muscle regeneration. PLoS One 2011, 6:e24714.
21. Ma K., Saha P.K., Chan L., Moore D.D. Farnesoid X receptor is essential for normal glucose homeostasis. Journal of Clinical Investigation 2006, 116:1102-1109.
22. Fu J., Akhmedov D., Berdeaux R. The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes. PLoS One 2013, 8:e78522.
23. Lan Z.J., Xu X., Cooney A.J. Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice. Biology of Reproduction 2004, 71:1469-1474.
24. Wang B., Moya N., Niessen S., Hoover H., Mihaylova M.M., Shaw R.J., et al. A hormone-dependent module regulating energy balance. Cell 2011, 145:596-606.
25. Mihaylova M.M., Vasquez D.S., Ravnskjaer K., Denechaud P.D., Yu R.T., Alvarez J.G., et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 2011, 145:607-621.
26. Patel K., Foretz M., Marion A., Campbell D.G., Gourlay R., Boudaba N., et al. The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. Nature Communications 2014, 5:4535.
27. Park J., Yoon Y.S., Han H.S., Kim Y.H., Ogawa Y., Park K.G., et al. SIK2 is critical in the regulation of lipid homeostasis and adipogenesis in vivo. Diabetes 2014, 63:3659-3673.
28. Itoh Y., Sanosaka M., Fuchino H., Yahara Y., Kumagai A., Takemoto D., et al. Salt inducible kinase 3 signaling is important for the gluconeogenic programs in mouse hepatocytes. Journal of Biological Chemistry 2015.
29. Katoh Y., Takemori H., Doi J., Okamoto M. Identification of the nuclear localization domain of salt-inducible kinase. Endocrine Research 2002, 28:315-318.
30. Seok S., Fu T., Choi S.E., Li Y., Zhu R., Kumar S., et al. Transcriptional regulation of autophagy by an FXR-CREB axis. Nature 2014, 516:108-111.
31. Erion D.M., Kotas M.E., McGlashon J., Yonemitsu S., Hsiao J.J., Nagai Y., et al. cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 2 (CRTC2) promotes glucagon clearance and hepatic amino acid catabolism to regulate glucose homeostasis. Journal of Biological Chemistry 2013, 288:16167-16176.
32. Sun Z., Miller R.A., Patel R.T., Chen J., Dhir R., Wang H., et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nature Medicine 2012, 18:934-942.
33. Postic C., Shiota M., Niswender K.D., Jetton T.L., Chen Y., Moates J.M., et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. Journal of Biological Chemistry 1999, 274:305-315.
34. Tallquist M.D., Weismann K.E., Hellstrom M., Soriano P. Early myotome specification regulates PDGFA expression and axial skeleton development. Development 2000, 127:5059-5070.
35. Eguchi J., Wang X., Yu S., Kershaw E.E., Chiu P.C., Dushay J., et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metabolism 2011, 13:249-259.
36. Bertorello A.M., Pires N., Igreja B., Pinho M.J., Vorkapic E., Wagsater D., et al. Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1). Circulation Research 2015, 116:642-652.
37. Shaw R.J., Lamia K.A., Vasquez D., Koo S.H., Bardeesy N., Depinho R.A., et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646.
38. Foretz M., Hebrard S., Leclerc J., Zarrinpashneh E., Soty M., Mithieux G., et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Journal of Clinical Investigation 2010, 120:2355-2369.
39. Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO Journal 2004, 23:833-843.
40. Sasagawa S., Takemori H., Uebi T., Ikegami D., Hiramatsu K., Ikegawa S., et al. SIK3 is essential for chondrocyte hypertrophy during skeletal development in mice. Development 2012, 139:1153-1163.
41. Uebi T., Itoh Y., Hatano O., Kumagai A., Sanosaka M., Sasaki T., et al. Involvement of SIK3 in glucose and lipid homeostasis in mice. PLoS One 2012, 7:e37803.
42. Henriksson E., Sall J., Gormand A., Wasserstrom S., Morrice N.A., Fritzen A.M., et al. SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes. Journal of Cell Science 2015, 128:472-486.
43. Cho H., Mu J., Kim J.K., Thorvaldsen J.L., Chu Q., Crenshaw E.B., et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 2001, 292:1728-1731.
44. JeBailey L., Wanono O., Niu W., Roessler J., Rudich A., Klip A. Ceramide- and oxidant-induced insulin resistance involve loss of insulin-dependent Rac-activation and actin remodeling in muscle cells. Diabetes 2007, 56:394-403.
45. Richter E.A., Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiological Reviews 2013, 93:993-1017.